Target Price | €51.00 |
Price | €47.10 |
Potential | 8.28% |
Number of Estimates | 20 |
20 Analysts have issued a price target Fresenius 2026 . The average Fresenius target price is €51.00. This is 8.28% higher than the current stock price. The highest price target is €55.65 18.15% , the lowest is €42.42 9.94% . | |
A rating was issued by 23 analysts: 20 Analysts recommend Fresenius to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Fresenius stock has an average upside potential 2026 of 8.28% . Most analysts recommend the Fresenius stock at Purchase. |
20 Analysts have issued a sales forecast Fresenius 2025 . The average Fresenius sales estimate is €22.9b . This is 2.88% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €24.5b 10.17% , the lowest is €21.9b 1.42% .
This results in the following potential growth metrics:
2024 | €21.8b | 3.64% |
---|---|---|
2025 | €22.9b | 4.74% |
2026 | €24.0b | 4.93% |
2027 | €25.2b | 4.87% |
2028 | €26.5b | 5.24% |
2029 | €27.7b | 4.48% |
2030 | €27.7b | 0.06% |
2031 | €28.8b | 4.23% |
19 Analysts have issued an Fresenius EBITDA forecast 2025. The average Fresenius EBITDA estimate is €3.8b . This is 68.61% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €4.1b 81.62% , the lowest is €3.3b 48.58% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €1.8b | 43.32% |
---|---|---|
2025 | €3.8b | 108.28% |
2026 | €4.1b | 8.35% |
2027 | €4.4b | 5.74% |
2028 | €4.5b | 3.95% |
2029 | €4.7b | 4.75% |
2024 | 8.35% | 38.29% |
---|---|---|
2025 | 16.60% | 98.81% |
2026 | 17.15% | 3.31% |
2027 | 17.29% | 0.82% |
2028 | 17.08% | 1.21% |
2029 | 17.12% | 0.23% |
19 Fresenius Analysts have issued a net profit forecast 2025. The average Fresenius net profit estimate is €1.9b . This is 65.93% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.1b 84.52% , the lowest is €1.4b 22.66% .
This results in the following potential growth metrics and future Net Margins:
2024 | €471m | 179.29% |
---|---|---|
2025 | €1.9b | 296.33% |
2026 | €2.1b | 11.35% |
2027 | €2.3b | 8.66% |
2028 | €2.5b | 11.73% |
2029 | €2.7b | 7.44% |
2030 | €2.7b | 1.04% |
2024 | 2.16% | 176.51% |
---|---|---|
2025 | 8.16% | 278.25% |
2026 | 8.66% | 6.13% |
2027 | 8.98% | 3.70% |
2028 | 9.53% | 6.12% |
2029 | 9.80% | 2.83% |
2030 | 9.91% | 1.12% |
19 Analysts have issued a Fresenius forecast for earnings per share. The average Fresenius EPS is €3.31 . This is 68.02% higher than earnings per share in the financial year 2024. The highest EPS forecast is €3.69 87.31% , the lowest is €2.45 24.37% .
This results in the following potential growth metrics and future valuations:
2024 | €0.83 | 179.05% |
---|---|---|
2025 | €3.31 | 298.80% |
2026 | €3.69 | 11.48% |
2027 | €4.01 | 8.67% |
2028 | €4.48 | 11.72% |
2029 | €4.81 | 7.37% |
2030 | €4.86 | 1.04% |
Current | 23.99 | 242.26% |
---|---|---|
2025 | 14.26 | 40.56% |
2026 | 12.81 | 10.17% |
2027 | 11.79 | 7.96% |
2028 | 10.55 | 10.52% |
2029 | 9.82 | 6.92% |
2030 | 9.72 | 1.02% |
Based on analysts' sales estimates for 2025, the Fresenius stock is valued at an EV/Sales of 1.59 and an P/S ratio of 1.15 .
This results in the following potential growth metrics and future valuations:
Current | 1.64 | 22.39% |
---|---|---|
2025 | 1.59 | 2.98% |
2026 | 1.52 | 4.70% |
2027 | 1.45 | 4.64% |
2028 | 1.37 | 4.97% |
2029 | 1.32 | 4.29% |
2030 | 1.32 | 0.06% |
2031 | 1.26 | 4.06% |
Current | 1.19 | 39.22% |
---|---|---|
2025 | 1.15 | 2.80% |
2026 | 1.10 | 4.70% |
2027 | 1.05 | 4.65% |
2028 | 0.99 | 4.98% |
2029 | 0.95 | 4.28% |
2030 | 0.95 | 0.05% |
2031 | 0.91 | 4.06% |
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Buy
➜
Buy
|
Unchanged | Jun 30 2025 |
DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Jun 08 2025 |
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
JEFFERIES |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
HSBC |
Buy
➜
Buy
|
Unchanged | May 25 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | May 22 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Hold
➜
Hold
|
Unchanged | May 07 2025 |
Analyst Rating | Date |
---|---|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Jun 30 2025 |
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Jun 08 2025 |
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
May 29 2025 |
Unchanged
JEFFERIES:
Buy
➜
Buy
|
May 29 2025 |
Unchanged
HSBC:
Buy
➜
Buy
|
May 25 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
May 22 2025 |
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Hold
➜
Hold
|
May 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.